217 Shares in The Clorox Company (NYSE:CLX) Purchased by Innealta Capital LLC

Innealta Capital LLC acquired a new stake in The Clorox Company (NYSE:CLX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 217 shares of the company’s stock, valued at approximately $30,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. CIBC Private Wealth Group LLC lifted its holdings in Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after purchasing an additional 66 shares during the last quarter. Lindbrook Capital LLC lifted its stake in shares of Clorox by 6.2% during the 1st quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after buying an additional 69 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Clorox by 14.3% during the 2nd quarter. Blue Trust Inc. now owns 678 shares of the company’s stock worth $93,000 after buying an additional 85 shares during the period. First National Bank of Omaha grew its stake in Clorox by 1.5% in the 4th quarter. First National Bank of Omaha now owns 5,975 shares of the company’s stock valued at $852,000 after buying an additional 86 shares during the last quarter. Finally, Diversify Advisory Services LLC grew its stake in Clorox by 3.9% in the 2nd quarter. Diversify Advisory Services LLC now owns 2,441 shares of the company’s stock valued at $322,000 after buying an additional 92 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $158.32 on Friday. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $159.05. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The stock’s 50-day simple moving average is $139.81 and its 200 day simple moving average is $142.52. The firm has a market capitalization of $19.66 billion, a PE ratio of 82.03, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 382.58%. On average, analysts anticipate that The Clorox Company will post 6.4 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.08%. This is a boost from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date was Tuesday, August 13th. Clorox’s dividend payout ratio is presently 252.85%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. reduced their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft upped their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Barclays lifted their target price on Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a report on Monday, August 5th. Citigroup upped their price target on shares of Clorox from $145.00 to $165.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Six equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $143.19.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.